patent/EP-0341258-B1

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1dd98ad4ee076841fec541542f952f58
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-212 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-21
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21
filingDate	1988-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate	1994-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2de398a18a63dad014c159de51fabe27
publicationDate	1994-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	EP-0341258-B1
titleOfInvention	Pharmaceutical composition containing interferon for buccal administration
abstract	Neoplastic disease, hyperallergenicity, autoimmune disorders characterized by chronic tissue degenerative inflammation and immuno-resistant viral infections are treated by the administration of interferon at a dosage of about 0.1 to about 5 IU/lb per day by contacting said interferon with oral/pharyngeal mucosa. Interferon is administered in solution or in a novel solid unitary dosage form adapted to be dissolved in saliva when placed in the mouth.
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2789513-C1
priorityDate	1986-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6992779 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402946 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1115 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127700386 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426902 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23830 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394880

Total number of triples: 21.